CD20

JOHANNESBURG, South Africa / HYDERABAD, India, Aug. 3, 2026 Dr. Reddy’s Laboratories South Africa announced the registration of an...

HYDERABAD, India, Aug. 1, 2026 Dr. Reddy’s Laboratories Ltd. announced that the U.S. Food and Drug Administration (FDA) has...

COPENHAGEN, Denmark and NORTH CHICAGO, Ill., July 23, 2026 Genmab and AbbVie have issued a clarification regarding the Phase...

BRONX, New York, July 6, 2026 Montefiore Einstein investigators have published new research demonstrating that expanding the use of...

LONDON, United Kingdom, July 6, 2026 AMO Pharma Limited has announced a significant regulatory milestone for its investigational therapy...

NORTH CHICAGO, Illinois, July 6, 2026 AbbVie has announced that the European Commission (EC) has granted marketing authorization for...

NEW YORK, July 6, 2026 TG Therapeutics, Inc. announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI®...

MISSISSAUGA, Ontario, May 22, 2026 Roche Canada announced that Canada’s Drug Agency (CDA-AMC) has issued a positive reimbursement recommendation...